Inhibikase Therapeutics Files SEC 8-K Disclosing Item 5.02
Inhibikase Therapeutics filed an SEC Form 8-K on Monday, October 20, 2026, disclosing Item 5.02 governance disclosures alongside Regulation FD disclosures under Item 7.01. Investors are reviewing the filing details for potential executive or board-level updates within the life sciences issuer.